Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors

DBCAT002190Pharmacologic classJ05AB

A DrugBank category of 13 drugs. 12 of them are approved.

Also known as
Antiviral nucleosides and nucleotides excl. reverse transcriptase inhibitors

What you can answer from here — as of May 26, 2021

13DrugsEach linked to its full drug card
Listed above
26Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,738Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
13Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account